Join to View Full Profile
10 Center DriveRm 13N240Bethesda, MD 20892
Dr. Floudas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Maimonides Medical CenterResidency, Internal Medicine, 2013 - 2016
University of Crete School of Health SciencesClass of 2000
Certifications & Licensure
MD State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009-20...Giovanni Maria Iannantuono, Charalampos S Floudas, Marco Filetti, Tommaso Giovagnoli, Stefano Sganga
European Journal of Cancer. 2025-06-26 - CRISPR screening identifiesco-mutations and downstream MEK signaling as a common key mechanism of sinonasal tumorigenesis.Kenny Vu, Sreenivasulu Gunti, Ramya Viswanathan, Anjali Nandal, Riley Larkin
Biorxiv. 2025-06-24 - 5 citationsNovel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial.Charalampos S Floudas, Meghali Goswami, Renee N Donahue, Danielle M Pastor, Jason M Redman
JAMA Oncology. 2025-04-01
Press Mentions
Cetuximab Outperforms Durvalumab for Head and Neck Cancer When Cisplatin Isn’t an OptionDecember 19th, 2024- Study in India Could Make Immunotherapy More Affordable WorldwideNovember 22nd, 2022
- Precigen Reports Second Quarter and First Half 2021 Financial ResultsAugust 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
